TABLE 3.
Features used | Variable type | Pathological + Clinical | Pathological + Clinical + MBD | Pathological + Clinical + LBD | Pathological + Clinical + MBD + Optical |
---|---|---|---|---|---|
Tumor size (cm) | Pathological | X | X | X | X |
ER status (−/+) | X | X | X | X | |
PR status (−/+) | X | X | X | X | |
Combined Nottingham grade (1/2/3) | X | X | X | X | |
Nuclear grade (1/2/3) | X | X | X | X | |
Mitotic grade (1/2/3) | X | X | X | X | |
Tubule formation grade (1/2/3) | X | X | X | X | |
Age (avg. ± σ) | Clinical | X | X | X | X |
BMI (avg. ± σ) | X | X | X | X | |
Mammographic density (MBD) | Imaging | X | X | ||
Local breast density (LBD) | X | X | |||
Risk prediction accuracy (r) | 0.89 | 0.91 | 0.93 | 0.98 | |
Area under the curve (AUC) | 0.86 | 0.88 | 0.92 | 0.97 |
Note: Risk prediction accuracy for different combinations of clinical, pathological and optical features.